Gene Expression Profiling of Suicide Completers
Overview
Affiliations
Despite strong evidence for a role of biological factors in the etiology and pathology of suicide, the study of traditional neurotransmitter systems has been able to explain only a small proportion of the neurobiology of what is now recognized as a complex genetic trait. The use of microarrays to simultaneously examine the expression levels of thousands of gene transcripts has vastly expanded our capacity to detect the involvement of additional genes and pathways in suicidality, and has opened many new avenues for the discovery of the biological underpinnings of suicide completion. This review examines microarray studies which have been used to identify genes displaying altered expression in suicide completers, and highlights some of the important methodological considerations and metabolic pathways which have emerged from these analyses.
Molecular mapping of a core transcriptional signature of microglia-specific genes in schizophrenia.
Fiorito A, Fakra E, Sescousse G, Ibrahim E, Rey R Transl Psychiatry. 2023; 13(1):386.
PMID: 38092734 PMC: 10719376. DOI: 10.1038/s41398-023-02677-y.
Identification of potential blood biomarkers associated with suicide in major depressive disorder.
Mamdani F, Weber M, Bunney B, Burke K, Cartagena P, Walsh D Transl Psychiatry. 2022; 12(1):159.
PMID: 35422091 PMC: 9010430. DOI: 10.1038/s41398-022-01918-w.
Cabrera B, Monroy-Jaramillo N, Fries G, Mendoza-Morales R, Garcia-Dolores F, Mendoza-Larios A Mol Neuropsychiatry. 2019; 5(1):60-73.
PMID: 31019919 PMC: 6465692. DOI: 10.1159/000493940.
Pantazatos S, Huang Y, Rosoklija G, Dwork A, Arango V, Mann J Mol Psychiatry. 2016; 22(5):760-773.
PMID: 27528462 PMC: 5313378. DOI: 10.1038/mp.2016.130.
Yin H, Pantazatos S, Galfalvy H, Huang Y, Rosoklija G, Dwork A Am J Med Genet B Neuropsychiatr Genet. 2016; 171B(3):414-426.
PMID: 26892569 PMC: 4851346. DOI: 10.1002/ajmg.b.32423.